Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl

Author(s): Carolina Q. Sacramento, Alessandro Kappel Jordão, Juliana L. Abrantes, Cristiane M. Alves, Andressa Marttorelli, Natalia Fintelman-Rodrigues, Caroline S. de Freitas, Gabrielle R. de Melo, Anna Claudia Cunha, Vitor F. Ferreira, Thiago Moreno L. Souza*

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 2 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Since the influenza virus is the main cause of acute seasonal respiratory infections and pandemic outbreaks, antiviral drugs are critical to mitigate infections and impair chain of transmission. Neuraminidase inhibitors (NAIs) are the main class of anti-influenza drugs in clinical use. Nevertheless, resistance to oseltamivir (OST), the most used NAI, has been detected in circulating strains of the influenza virus. Therefore, novel compounds with anti-influenza activity are necessary.

Objective: To verify whether the NA from influenza A and B virus is susceptible to the compound 4-(4- phenyl-1H-1,2,3-triazol-1-yl)-2,2,6,6-tetramethylpiperidine-1-oxyl (Tritempo).

Methods: Cell-free neuraminidase inhibition assays were performed with Tritempo, using wild-type (WT) and OST-resistant influenza strains. Cell-based assays in MDCKs were performed to confirm Tritempo`s antiviral activity and cytotoxicity. Multiple passages of the influenza virus in increasing concentrations of our compound, followed by the sequencing of NA gene and molecular docking, were used to identify our Tritempo’s target.

Results and Discussion: Indeed, Tritempo inhibited the neuraminidase activity of WT and OSTresistant strains of influenza A and B, at the nanomolar range. Tritempo bound to WT and OST-resistant influenza NA isoforms at the sialic acid binding site with low free binding energies. Cell-free assays were confirmed using a prototypic influenza A infection assay in MDCK cells, in which we found an EC50 of 0.38 µM, along with very low cytotoxicity, CC50 > 2,000 µM. When we passaged the influenza A virus in the presence of Tritempo, a mutant virus with the G248P change in the NA was detected. This mutant was resistant to Tritempo but remained sensitive to OST, indicating no cross-resistance between the studied and reference drugs.

Conclusion: Our results suggest that Tritempo’s chemical structure is a promising one for the development of novel antivirals against influenza.

Keywords: Influenza virus, Neuraminidase, Oseltamivir-resistant, Triazolic compounds, Nitroxide radical, Hemagglutinin (HA).

Murphy, B.R.; Webster, R.G. Orthomyxoviruses In: Virology, Fields; Ed., Philadelphia: Lappincott-Raven Publishers, 1996.
Tang, J.W.; Shetty, N.; Lam, T.T.; Hon, K.L. Emerging, novel, and known influenza virus infections in humans. Infect. Dis. Clin. North Am., 2010, 24(3), 603-617.
[] [PMID: 20674794]
Palese, P.; Shaw, M.L. Orthomyxoviridae: The viruses and their replication. In: Fields Virology; Fifth Edition, Knipe, D.M.; Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia:, ; pp. 1647-1690.
Das, K.; Aramini, J.M.; Ma, L.C.; Krug, R.M.; Arnold, E. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol., 2010, 17(5), 530-538.
[] [PMID: 20383144]
von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov., 2007, 6(12), 967-974.
[] [PMID: 18049471]
De Clercq, E.; Li, G. Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev., 2016, 29(3), 695-747.
[] [PMID: 27281742]
Jefferson, T.; Jones, M.; Doshi, P.; Spencer, E.A.; Onakpoya, I.; Heneghan, C.J. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ, 2014, 348, g2545.
[] [PMID: 24811411]
Fry, A.M.; Gubareva, L.V. Understanding influenza virus resistance to antiviral agents; early warning signs for wider community circulation. J. Infect. Dis., 2012, 206(2), 145-147.
[] [PMID: 22561368]
Hurt, A.C.; Hardie, K.; Wilson, N.J.; Deng, Y.M.; Osbourn, M.; Leang, S.K.; Lee, R.T.; Iannello, P.; Gehrig, N.; Shaw, R.; Wark, P.; Caldwell, N.; Givney, R.C.; Xue, L.; Maurer-Stroh, S.; Dwyer, D.E.; Wang, B.; Smith, D.W.; Levy, A.; Booy, R.; Dixit, R.; Merritt, T.; Kelso, A.; Dalton, C.; Durrheim, D.; Barr, I.G. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J. Infect. Dis., 2012, 206(2), 148-157.
[] [PMID: 22561367]
Souza, T.M.; Resende, P.C.; Fintelman-Rodrigues, N.; Gregianini, T.S.; Ikuta, N.; Fernandes, S.B.; Cury, A.L. Rosa, Mdo.C.; Siqueira, M.M. Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out? PLoS One, 2013, 8(11)e80081
[] [PMID: 24244615]
Boechat, F.C.; Sacramento, C.Q.; Cunha, A.C.; Sagrillo, F.S.; Nogueira, C.M.; Fintelman-Rodrigues, N.; Santos-Filho, O.; Riscado, C.S. Forezi. L.daS.; Faro, L.V.; Brozeguini, L.; Marques, I.P.; Ferreira, V.F.; Souza, T.M.; de Souza, M.C. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses. Bioorg. Med. Chem., 2015, 23(24), 7777-7784.
[] [PMID: 26643220]
Lourdes, G.; Ferreira, M.; Pinheiro, L.C.S.; Santos-Filho, O.A.; Peçanha, M.D.S.; Sacramento, C.Q.; Machado, V.; Ferreira, V.F.; Souza, T.M.L.; Boechat, N. Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs. Med. Chem. Res., 2013, 23, 1501-1511.
Jordão, A.K.; Ferreira, V.F.; Souza, T.M.; Faria, G.G.; Machado, V.; Abrantes, J.L.; de Souza, M.C.; Cunha, A.C. Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives. Bioorg. Med. Chem., 2011, 19(6), 1860-1865.
[] [PMID: 21376603]
Queiroz, R.F.; Jordão, A.K.; Cunha, A.C.; Ferreira, V.F.; Brigagão, M.R.; Malvezzi, A.; Amaral, A.T.; Augusto, O. Nitroxides attenuate carrageenan-induced inflammation in rat paws by reducing neutrophil infiltration and the resulting myeloperoxidase-mediated damage. Free Radic. Biol. Med., 2012, 53(10), 1942-1953.
[] [PMID: 22982597]
Dumitru, G.; El-Nashar, H.A.S.; Mostafa, M.N.; Eldahshan, O.A.; Boiangiu, R.S.; Todirascu-Ciornea, E.; Abdel, L.H.; Singab, N.B. Agathisflavone isolated from Schinus polygamus (Cav.) Cabrera leaves prevents scopolamine-induced memory impairment and brain oxidative stress in zebrafish (Danio rerio). Phytomedicine, 2019, Vol 58 152889
World Health Organization (WHO). Serological Diagnosis of Influenza by Microneutralization Assay. 2017, Available from.
Baillie, G.J.; Galiano, M.; Agapow, P.M.; Myers, R.; Chiam, R.; Gall, A.; Palser, A.L.; Watson, S.J.; Hedge, J.; Underwood, A.; Platt, S.; McLean, E.; Pebody, R.G.; Rambaut, A.; Green, J.; Daniels, R.; Pybus, O.G.; Kellam, P.; Zambon, M. Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis. J. Virol., 2012, 86(1), 11-18.
[] [PMID: 22013031]
Joy, S.; Nair, P.S.; Hariharan, R.; Pillai, M.R. Detailed comparison of the protein-ligand docking efficiencies of GOLD, a commercial package and ArgusLab, a licensable freeware.In Silico Biol. (Gedrukt); , 2006, 6, pp. (6)601-605.
[PMID: 17518767]
Bernstein, F.C.; Koetzle, T.F.; Williams, G.J.; Meyer, E.F., Jr; Brice, M.D.; Rodgers, J.R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank. A computer-based archival file for macromolecular structures. Eur. J. Biochem., 1977, 80(2), 319-324.
[] [PMID: 923582]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 19 February, 2020
Page: [132 - 139]
Pages: 8
DOI: 10.2174/1568026620666191227142433
Price: $65

Article Metrics

PDF: 27